BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31705658)

  • 1. Respirovirus C protein inhibits activation of type I interferon receptor-associated kinases to block JAK-STAT signaling.
    Kitagawa Y; Yamaguchi M; Kohno M; Sakai M; Itoh M; Gotoh B
    FEBS Lett; 2020 Mar; 594(5):864-877. PubMed ID: 31705658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction.
    Bisson SA; Page AL; Ganem D
    J Virol; 2009 May; 83(10):5056-66. PubMed ID: 19279093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
    Zaritsky LA; Bedsaul JR; Zoon KC
    J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription.
    Komatsu T; Takeuchi K; Yokoo J; Tanaka Y; Gotoh B
    J Virol; 2000 Mar; 74(5):2477-80. PubMed ID: 10666284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway.
    Chen DY; Khan N; Close BJ; Goel RK; Blum B; Tavares AH; Kenney D; Conway HL; Ewoldt JK; Chitalia VC; Crossland NA; Chen CS; Kotton DN; Baker SC; Fuchs SY; Connor JH; Douam F; Emili A; Saeed M
    J Virol; 2021 Sep; 95(19):e0086221. PubMed ID: 34260266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
    Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
    J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes Simplex Virus 1 UL36USP Antagonizes Type I Interferon-Mediated Antiviral Innate Immunity.
    Yuan H; You J; You H; Zheng C
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance.
    Shang D; Liu Y; Ito N; Kamoto T; Ogawa O
    Cancer Sci; 2007 Aug; 98(8):1259-64. PubMed ID: 17573897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudorabies Virus Inhibits Type I and Type III Interferon-Induced Signaling via Proteasomal Degradation of Janus Kinases.
    Yin Y; Romero N; Favoreel HW
    J Virol; 2021 Sep; 95(20):e0079321. PubMed ID: 34379505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
    Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
    Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism.
    Lin RJ; Chang BL; Yu HP; Liao CL; Lin YL
    J Virol; 2006 Jun; 80(12):5908-18. PubMed ID: 16731929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinase-deficient forms of Jak1 and Tyk2 inhibit interferon alpha signaling in a dominant manner.
    Krishnan K; Pine R; Krolewski JJ
    Eur J Biochem; 1997 Jul; 247(1):298-305. PubMed ID: 9249040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM10 binds to IFN-α/β receptor 1 to negatively regulate type I IFN signal transduction.
    Guo M; Cao W; Chen S; Tian R; Wang L; Liu Q; Zhang L; Wang Z; Zhao M; Lu Q; Zhu H
    Eur J Immunol; 2021 Jul; 51(7):1762-1773. PubMed ID: 33811647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
    Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
    Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Heterodimers of Type III Interferon Receptors Require TYK2 for STAT Activation.
    Mesev EV; Guare EG; Ploss A; Toettcher JE
    J Interferon Cytokine Res; 2023 Sep; 43(9):414-426. PubMed ID: 37725008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel viral SOCS from infectious spleen and kidney necrosis virus: interacts with Jak1 and inhibits IFN-α induced Stat1/3 activation.
    Guo CJ; Yang LS; Zhang YF; Wu YY; Weng SP; Yu XQ; He JG
    PLoS One; 2012; 7(7):e41092. PubMed ID: 22844427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating STATs.
    Shemesh M; Lochte S; Piehler J; Schreiber G
    Sci Signal; 2021 Nov; 14(710):eabe4627. PubMed ID: 34813358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sendai virus C protein inhibits lipopolysaccharide-induced nitric oxide production through impairing interferon-β signaling.
    Odkhuu E; Komatsu T; Naiki Y; Koide N; Yokochi T
    Int Immunopharmacol; 2014 Nov; 23(1):267-72. PubMed ID: 25242386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired type I IFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-/- mice.
    Fagerlie SR; Koretsky T; Torok-Storb B; Bagby GC
    J Immunol; 2004 Sep; 173(6):3863-70. PubMed ID: 15356134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.